Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Weightlessness Simulation | 5 | 2008 | 21 | 0.820 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 626 | 0.470 |
Why?
|
| Keratinocytes | 2 | 2008 | 66 | 0.370 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 306 | 0.350 |
Why?
|
| Hepatoblastoma | 1 | 2007 | 3 | 0.300 |
Why?
|
| Environmental Monitoring | 2 | 2005 | 192 | 0.270 |
Why?
|
| Air | 1 | 2005 | 18 | 0.250 |
Why?
|
| Organic Chemicals | 1 | 2005 | 35 | 0.250 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 190 | 0.250 |
Why?
|
| Air Pollutants | 1 | 2005 | 94 | 0.230 |
Why?
|
| Nanotubes, Carbon | 3 | 2011 | 79 | 0.230 |
Why?
|
| Mycotoxins | 1 | 2003 | 12 | 0.220 |
Why?
|
| Air Pollution, Indoor | 1 | 2003 | 41 | 0.210 |
Why?
|
| Fungi | 1 | 2003 | 89 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 807 | 0.200 |
Why?
|
| Environmental Exposure | 1 | 2003 | 216 | 0.190 |
Why?
|
| Weightlessness | 2 | 2008 | 16 | 0.160 |
Why?
|
| Lung | 3 | 2011 | 446 | 0.160 |
Why?
|
| Blotting, Northern | 2 | 2008 | 150 | 0.150 |
Why?
|
| Cell Culture Techniques | 2 | 2008 | 142 | 0.140 |
Why?
|
| Oxidative Stress | 4 | 2011 | 938 | 0.130 |
Why?
|
| Epithelial Cells | 2 | 2008 | 384 | 0.120 |
Why?
|
| Proteomics | 2 | 2008 | 325 | 0.120 |
Why?
|
| Time Factors | 3 | 2008 | 1742 | 0.120 |
Why?
|
| NF-kappa B | 2 | 2008 | 339 | 0.120 |
Why?
|
| Apoptosis | 3 | 2011 | 1398 | 0.110 |
Why?
|
| Texas | 2 | 2005 | 324 | 0.110 |
Why?
|
| Cell Line | 4 | 2008 | 1354 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 1015 | 0.100 |
Why?
|
| Materials Testing | 1 | 2011 | 69 | 0.100 |
Why?
|
| Pulmonary Fibrosis | 1 | 2011 | 31 | 0.100 |
Why?
|
| Pneumonia | 1 | 2011 | 54 | 0.090 |
Why?
|
| Reactive Oxygen Species | 3 | 2007 | 461 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 5 | 2011 | 661 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2008 | 73 | 0.080 |
Why?
|
| Gravitation | 1 | 2008 | 7 | 0.080 |
Why?
|
| Bioreactors | 1 | 2008 | 21 | 0.080 |
Why?
|
| Brain | 2 | 2006 | 1346 | 0.080 |
Why?
|
| Rotation | 1 | 2007 | 24 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2008 | 195 | 0.070 |
Why?
|
| Hypothalamus | 1 | 2008 | 129 | 0.070 |
Why?
|
| Foreskin | 1 | 2007 | 4 | 0.070 |
Why?
|
| Respiratory Mucosa | 1 | 2007 | 43 | 0.070 |
Why?
|
| Testis | 1 | 2008 | 187 | 0.070 |
Why?
|
| Transcription Factor AP-1 | 1 | 2006 | 35 | 0.070 |
Why?
|
| Nanotechnology | 1 | 2007 | 153 | 0.070 |
Why?
|
| Caspase 8 | 3 | 2011 | 32 | 0.060 |
Why?
|
| Industrial Waste | 1 | 2005 | 16 | 0.060 |
Why?
|
| Volatilization | 1 | 2005 | 23 | 0.060 |
Why?
|
| Urbanization | 1 | 2005 | 11 | 0.060 |
Why?
|
| Vehicle Emissions | 1 | 2005 | 23 | 0.060 |
Why?
|
| Proteome | 1 | 2006 | 144 | 0.060 |
Why?
|
| Caspase 3 | 3 | 2011 | 207 | 0.060 |
Why?
|
| Construction Materials | 1 | 2003 | 4 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2007 | 1207 | 0.050 |
Why?
|
| Cities | 1 | 2003 | 63 | 0.050 |
Why?
|
| Hippocampus | 1 | 2006 | 561 | 0.050 |
Why?
|
| Mice | 6 | 2011 | 5913 | 0.050 |
Why?
|
| Housing | 1 | 2003 | 59 | 0.050 |
Why?
|
| Disasters | 1 | 2003 | 65 | 0.050 |
Why?
|
| Animals | 8 | 2011 | 15081 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 2231 | 0.050 |
Why?
|
| Humans | 4 | 2008 | 37093 | 0.040 |
Why?
|
| Public Health | 1 | 2003 | 372 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2008 | 103 | 0.040 |
Why?
|
| Glutathione | 2 | 2008 | 179 | 0.030 |
Why?
|
| Aerosols | 1 | 2011 | 48 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2011 | 87 | 0.020 |
Why?
|
| Male | 5 | 2008 | 20025 | 0.020 |
Why?
|
| Rats | 2 | 2008 | 3483 | 0.020 |
Why?
|
| Electron Transport Complex IV | 1 | 2008 | 37 | 0.020 |
Why?
|
| Permeability | 1 | 2008 | 67 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 133 | 0.020 |
Why?
|
| Peroxiredoxin VI | 1 | 2008 | 1 | 0.020 |
Why?
|
| Mitochondrial Membranes | 1 | 2008 | 40 | 0.020 |
Why?
|
| Malate Dehydrogenase | 1 | 2008 | 7 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 78 | 0.020 |
Why?
|
| Organ Size | 1 | 2008 | 157 | 0.020 |
Why?
|
| Antioxidants | 1 | 2011 | 416 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2008 | 155 | 0.020 |
Why?
|
| Dimethylformamide | 1 | 2007 | 8 | 0.020 |
Why?
|
| Testosterone | 1 | 2008 | 193 | 0.020 |
Why?
|
| Solvents | 1 | 2007 | 99 | 0.020 |
Why?
|
| beta-Synuclein | 1 | 2006 | 2 | 0.020 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2006 | 5 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2006 | 12 | 0.020 |
Why?
|
| Body Weight | 1 | 2008 | 434 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2006 | 82 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2006 | 176 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1039 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2006 | 77 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2005 | 22 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 623 | 0.020 |
Why?
|
| Kinetics | 1 | 2007 | 708 | 0.020 |
Why?
|
| Hindlimb | 1 | 2005 | 27 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2006 | 444 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2005 | 140 | 0.020 |
Why?
|
| Gene Expression | 1 | 2007 | 674 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 366 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2008 | 1908 | 0.010 |
Why?
|